---
document_datetime: 2023-09-21 19:12:54
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/integrilin-epar-all-authorised-presentations_en.pdf
document_name: integrilin-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.3367326
conversion_datetime: 2025-12-14 23:28:09.094097
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
## EU numbers Invented name Strengths Pharmaceutical Forms Route of administration Packaging Content Package size

EU/1/99/109/001 Integrilin 0.75 mg/ml Solution for infusion Intravenous use Vial (glass) 100 ml 1 vial EU/1/99/109/002 Integrilin 2 mg/ml Solution for injection Intravenous use Vial (glass) 10 ml 1 vial